Perea CRA, Rodríguez SRB, Barrera JI

Language: Spanish
References: 6
Page: 93
PDF size: 170.82 Kb.

Text Extraction

REFERENCES

1. Fine MJ, Aubic TE, Yealy DM. Prediction rule to identify low risk patients with community acquired pneumonia. N Engl J Med. 1997; 336: 243-50.

2. Bantar C, et al. Pharmacodynamic model to support a 12 hour dosing material for amoxicilin/sulbactam oral combination, in the treatment of community- acquired lower respiratory tract infections. J Chemoter. 2000; 12: 223-7.

3. Guillermont D, et al. Low dosage and long treatment duration of blactam : risk factors for carriage of penicilin-resistant Streptococcus pneumoniae. JAMA. 1998; 279: 365-70.

4. Kristinsson KG. Epidemiology of penicilin resistant pneumococci in Iceland. Microb Drug Resist. 1995: 1: 121-12.

5. Meziane-Cherif D, et al. Genetic and biochemical characterization of CAD-1, a chromosomally encoded new class a penicillinase from carnobacterium divergens. Antimicrob Agents Chemother. 2008; 52: 551-6.

6. CLSI/ NCCLS Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically Approved standard. 6th ed. M07- A6 CLSI Wayne Philadelphia USA 2005.